Aleksandr Rumyantsev

Prof. Dr. Aleksandr Rumyantsev

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2020 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Open access
PDF file
ASA. V. Smirnov
A. V. Smirnov
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
Острое повреждение почек. Часть I

18 February 2022 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
MPM. O. Pyatchenkov
M. O. Pyatchenkov
AMAlexander G Markov
Alexander G Markov
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
The gut microbiota is an essential part of the human organism, which plays a crucial role in maintaining its homeostasis. Peaceful coexistence with trillions of microorganisms mainly depends on the normal functioning of cellular and extracellular components of the intestinal mucosa, often called the "intestinal barrier". This barrier protects the organism against pathogenic infections while and at the same time satisfying its requirements for digestion and absorption of nutrients. It is not surprising that structural and functional intestinal barrier abnormalities are involved in the pathogenesis of many diseases including various nephropathies. The pathogenetic interconnection between the intestine and the kidneys is bidirectional. On the one hand, uremia affects the microbiota composition and the integrity of the intestinal epithelium. On the other hand, uremic toxins translocation, formed as a result of abnormal microbial metabolism, from the intestine into circulation through the ultra-permeable barrier contributes to the progression of renal dysfunction. Furthermore, according to a number of researchers, dysbiosis and the leaky gut syndrome are considered as one of the possible causes of anemia, nutritional disorders, cardiovascular and many other complications, often diagnosed in patients with chronic renal disease. The first part of the review reflects modern data about normal intestinal barrier structure and physiology, as well as methods for studying the intestinal wall integrity and permeability. The significant role of microbiota in the regulation of the barrier properties of the intestinal mucous and epithelial layer is emphasizing. The main differences between the intestinal microflora of patients with nephropathies from healthy people are presented, possible causes of their occurrence are discussed.

21 July 2018 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
BLB. G. Lukichev
B. G. Lukichev
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
VAV. Akimenko
V. Akimenko
Interest in studying the role of the gastrointestinal tract in maintaining homeostasis in chronic kidney disease is a traditional one. It served, in particular, as a starting point for the creation of enterosorbents. However, if earlier the main attention was paid to the mechanical removal of a number of potentially dangerous biologically active substances, recently an intestinal microbiota has become an object of interest. The first part of the literature review on this topic is devoted to questions of terminology, the normal physiology of the colon microbiota. A detailed description of dysbiosis is given. The features of the main groups of microorganisms are reflected. The hypothetical and confirmed interrelations of the intestine-kidney axis are presented. The pathogenetic mechanisms of the colon dysbiosis influence on the processes of local and systemic inflammation are discussed. The influence of dysbiosis on the state of the kidney parenchyma and its participation in the progression of CKD are debated.

1 January 2017 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
PDF file
ASA. V. Smirnov
A. V. Smirnov
RGR. V. Golubev
R. V. Golubev
NKN. Yu. Korosteleva
N. Yu. Korosteleva
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
Саркопения является важной причиной снижения физической работоспособности у больных, получающих заместительную почечную терапию. Обсуждаются критерии диагностики, механизмы ее развития и методы коррекции.

3 March 2017 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Open access
PDF file
ASA. V. Smirnov
A. V. Smirnov
IKI. G. Kayukov
I. G. Kayukov
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
The article discusses the problem of choosing an adequate method of assessing glomerular filtration rate in overweight and obesity.

1 January 2018 in Nephrology (Saint-Petersburg)
Verified
Journal Article
Closed access
AZA. Yu. Zemchenkov
A. Yu. Zemchenkov
ARAleksandr Rumyantsev
Aleksandr Rumyantsev
ASA. V. Smirnov
A. V. Smirnov
Распространенность терминальной почечной недостаточности в мире имеет тенденцию к увеличению, что создает значительную дополнительную нагрузку на систему здравоохранения. Это особенно актуально для стран со средним и невысоким валовым национальным доходом относительно численности населения. В статье рассмотрены основные направления и себестоимость нефропротективной терапии. Основными ее компонентами являются интенсификация антигипертензивного лечения, двойная блокада ренин-ангиотензиновой системы, контроль гиперлипидемии статинами, коррекция анемии и недостаточности витамина D, нутриционная поддержка, прекращение курения, ограничение потребления поваренной соли и модификация стиля жизни. По данным регистра Санкт-Петербурга, наиболее частыми причинами терминальной почечной недостаточности являются хронический гломерулонефрит (20%), сахарный диабет (16,7%), гипертоническая болезнь (11,8%). У 19,7% диагноз не установлен. Нефропротективная терапия позволяет увеличить длительность додиализного периода на 1,5–2,0 года. При этом рассматриваются минимальные критерии эффективности: снижение величины систолического артериального давления на 5 мм рт. ст. и протеинурии на 0,3 г/сут. В расчете на 1 больного затраты на нефропротекцию составляют 63 100 рублей в год, тогда как на диализное лечение – 933 005 рублей в год.